Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 5Phase 1 5Phase 4 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia, Myeloid, Acute 11Neoplasm, Residual 3Leukemia 3Recurrence 2Leukemia, Promyelocytic, Acute 2Burkitt Lymphoma 2Myelodysplastic Syndromes 1Meningitis 1Meningeal Neoplasms 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Idarubicin 3Arsenic Trioxide 3Mitoxantrone 2Cytarabine 2Tretinoin 1Transplantation, Autologous 1Thiotepa 1Radiotherapy 1Filgrastim 1Daunorubicin 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Promyelocytic, Acute × Cytarabine × Clear all
NCT00408278 2014-10-28

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

PETHEMA Foundation

Phase 4 Completed
300 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00180128 2011-07-11

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Technische Universität Dresden

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡